STRONGER TOGETHER, a randomized control trial HIV in male partnerships, finished enrollment this year with 32 couples. The study examines the efficacy of intervention such as Couples HIV Testing and Counseling (CHTC) and Partner STEPS, a curriculum developed at Fenway aimed at improving adherence in HIV positive people and serodiscordant couples. The Stronger Together team published two protocol papers in JMIR Research Protocols, and the study continues with active follow-up visits and retention.
THE NEXUS STUDY for male sex workers was completed and data analysis is underway. There is little research on male sex workers or understanding of how networks of male sex workers facilitate or impede HIV infection and transmission. The Nexus Study’s innovative approach focuses on the social, sexual and drug use networks of this high-risk population.
PROJECT AMP researchers screened 75 people and enrolled 56 participants into the study this year. The AMP Study tests an experimental antibody against HIV. Participants are given an antibody to determine if it will protect against HIV infection.
The Fenway Institute served as a research site for HIV vaccine study HVTN 117, screening 24 and enrolling 13 participants.
DISCOVER, a study comparing a new drug combination for PrEP compared to the widely used Truvada, enrolled 36 participants during a four month enrollment period.